868.85 24.45 (2.90%)

34.39% Fall from 52W High

1.2M NSE+BSE Volume

NSE 11 Apr, 2025 3:31 PM (IST)

US FDA Approval
Zydus Life receives final approval from the US FDA to manufacture Jaythari (Deflazacort) tablets See details

Zydus Lifesciences Ltd. quarterly, annual results, revenue, profit, P&L, Balance Sheet, Cash Flow, Annual Reports, Margins - 15 Years history